Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-4681
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study ; day:30 ; month:3 ; year:2021 ; pages:1-13
Annals of surgical oncology ; (30.3.2021), 1-13
- Urheber
-
Kamarajah, Sivesh K.
White, Steven A.
Naffouje, Samer A.
Salti, George I.
Dahdaleh, Fadi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-021-09823-0
- URN
-
urn:nbn:de:101:1-2021052521563293697896
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kamarajah, Sivesh K.
- White, Steven A.
- Naffouje, Samer A.
- Salti, George I.
- Dahdaleh, Fadi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adjuvant vs Neoadjuvant Chemotherapy In Advanced Ovarian Cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data
Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study
Adjuvant vs Neoadjuvant Chemotherapy In Advanced Ovarian Cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data
Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study
Adjuvant vs Neoadjuvant Chemotherapy In Advanced Ovarian Cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data
Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer